Serum Prealbumin is prognostic for All-cause Mortality in Patients with Community-acquired and Post-operative Acute Kidney Injury.
To study the influence of prealbumin (PA) on all-cause mortality in patients with acute kidney injury (AKI). From 2000 to 2010, 477 patients diagnosed with AKI and treated in the Department of Nephrology, Ruijin Hospital, Shanghai Jiaotong University were enrolled in the community-acquired AKI (CA-AKI) group and 138 patients diagnosed with AKI after an operation were enrolled in the post-operative AKI (PO-AKI) group. Data were collected at AKI onset and 1 year after discharge and analyzed retrospectively. Compared with PO-AKI patients, more patients in CA-AKI group had chronic kidney disease, obesity, and hyperlipidemia, and fewer patients had cerebrovascular disease (CVD), anemia, shock, or arrhythmia. Risks for CA-AKI were atherosclerosis, CVD, arrhythmia, multiple organ dysfunction syndrome, and usage of vasoactive agents, and risks for PO-AKI were elderly, arrhythmia, and requirement of renal replacement therapy. A higher level of serum PA was associated with a better outcome in the CA-AKI group (hazard ratio [HR] 0.92, 95% confidence interval [CI] 0.85-0.996) and PO-AKI group (HR 0.91, 95% CI 0.84-0.99). In the CA-AKI group, the cumulative survival rate of patients with a normal PA level (PA >20 mg/dL) was higher than that among patients with a lower PA (PA ≤ 20 mg/dL; 95.4% vs 88.3%, P=0.031). Similarly, in the PO-AKI group, a normal PA level was associated with a higher survival rate (74.1% vs 47.6%, P=0.019). Serum PA may serve as a prognostic marker for CA-AKI and PO-AKI, and further research is warranted to confirm this finding. This article is protected by copyright. All rights reserved.